Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 AI News That Broke The Internet

Page 1 of 14

One conversation gaining traction in Silicon Valley these days is how the advancement of Generative AI models is slowing down. Deirdre Bosa takes a look at the matter in CNBC’s TechCheck, revealing how rapid genAI advancements are now showing signs of deceleration. She notes how the quality of improvement in OpenAI’s upcoming model, Orion, is expected to be smaller than the leap from ChatGPT-3 to ChatGPT-4. This smaller advancement is largely due to a limited supply of training data, a key factor that could significantly affect how investors view AI companies.

READ ALSO: 15 AI News That Should Not Be Ignored and 10 Trending AI Stocks on Latest Analyst Ratings and News 

Nevertheless, OpenAI CEO Sam Altman has boasted on X that ChatGPT is now the eighth-biggest website in the world by traffic. As of October, ChatGPT had 3.7 billion visits, versus Perplexity’s 91 million visits, and Google Gemini’s 292 million visits. Nevertheless, the plateau in technology advancement doesn’t necessarily mean a slowdown. For instance, Mark Zuckerberg proposes that there is a lot of opportunity to build consumer enterprise applications on top of the existing technology.

While that is certainly an option, Reuters has reported that artificial intelligence companies are seeking a new path to smarter AI due to the plateau. Ilya Sutskever, co-founder of AI labs Safe Superintelligence (SSI) and OpenAI, told Reuters recently that scaling up pre-training for AI models, which involves using large amounts of unlabeled data to learn language patterns, has reached a plateau.

“The 2010s were the age of scaling, now we’re back in the age of wonder and discovery once again. Everyone is looking for the next thing. Scaling the right thing matters more now than ever”.

-Sutskever

In light of this, researchers are now looking at a technique called “time testing compute” for improving models during the “inference” phase when such models are being used. The technique will allow the model to test different options instead of giving a single answer. The implications of the technique are far-fetched, having the potential to change the competitive landscape for AI hardware.

Recent AI Developments

Fortune predicts that GenAI funding is going to decelerate this year. However, it also believes that the industry’s recent breakthroughs are among the most profound technological advancements of our time. Regardless of the slowdown in GenAI models, artificial intelligence continues to be a breakthrough in many industries today.

In its first, an artificial intelligence company will be helping publishers rather than attempting to steal its work. While AI isn’t much appreciated in journalism because it seemingly uses journalist work to feed chatbot’s data demands and in turn diverts lesser traffic to the publisher, one startup, founded by Twitter engineers, believes that AI could be a valuable player in the media industry instead. Particle, an AI newsreader, will help readers better understand the news with the help of AI technology, offering more than just a summary.

In other developments, Perplexity, an AI-powered search engine, says it will begin experimenting with ads this week.

“Ad programs like this help us generate revenue to share with our publisher partners. Experience has taught us that subscriptions alone do not generate enough revenue to create a sustainable revenue-sharing program. Advertising is the best way to ensure a steady and scalable revenue stream.”

– Perplexity wrote in a post on its blog.

For this article, we selected AI stocks by going through news articles, stock analysis, and press releases. These stocks are also popular among hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

15. Verint Systems Inc. (NASDAQ:VRNT)

Market Capitalization: $1.55 billion

Verint Systems Inc. (NASDAQ:VRNT) is a technology company that provides customer engagement solutions worldwide. Having launched its AI business software platform in 2023, the company focuses on AI-powered analytics and customer engagement solutions.

On November 11, Verint Systems Inc. (NASDAQ:VRNT) announced that a top telecommunications company raked in $10.5 million in annual savings by leveraging the Verint Intelligent Virtual Assistant (IVA) to power their contact center telephony self-service. Each year, the said telecommunications company receives over seven million calls on topics such as billing, payment, and tech support. The use of Verint AI-powered IVA allowed it to handle half of these calls without live agents, including 80% of billing-related calls. In total, Verint’s solution enables the company to contain 3.5 million calls, avoiding the need to transfer to live agents and helping save $10.5 million annually.

“Verint IVA is built on industry-leading conversational AI that trains on an organization’s unique engagement data. This means the Verint AI-powered bots continuously improve and provide consumers with relevant, accurate responses, even within environments of higher conversational complexity or specificity to the business. With Verint’s leadership in AI-powered self-service bots, organizations are reporting strong AI business outcomes after replacing their legacy telephony-driven IVR systems.”

– Verint’s Heather Richards, vice president, Go-to-Market Strategy.

14. SoundHound AI (NASDAQ:SOUN)

Market Capitalization: $2.71 billion

SoundHound AI (NASDAQ:SOUN) is a voice artificial intelligence platform offering voice AI solutions to businesses. The company is emerging as a leader in conversational AI with more than 200 enterprise brands employing its AI agents across a growing number of verticals.

SoundHound AI (NASDAQ:SOUN) reported its third-quarter financial results on November 12, 2024. The company reported a revenue of $25.1 million, beating the consensus estimate of $23.02 million. It reported an adjusted loss of six cents per share, outperforming analyst estimates of a loss of seven cents per share. According to CEO and Co-Founder, Keyvan Mohajer, this quarter has been the most successful for the company as it takes on and expands into “important new verticals” such as healthcare, finance, and insurance. This growth is further exemplified through its strategic acquisition of Amelia, a global leader in enterprise AI agent software. Conversational artificial intelligence has been leading the company’s scale and market enthusiasm, allowing it to capitalize on emerging opportunities across industries. The company raised its full-year revenue guidance for the upcoming year, now projecting between $155 million and $175 million, up from the previous estimate of $150 million.

“We believe that voice is the ‘killer app’ for applied generative AI. Thanks to our best-in-class technology, mastery of complex vertical integrations, and proprietary AI software, SoundHound is ideally positioned to capitalize on this huge and growing opportunity.”

Keyvan Mohajer, CEO and Co-Founder, SoundHound AI

Page 1 of 14

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…